$CALM

How Investors Are Reacting To Cal-Maine Foods (CALM) Sudden Swing From Profit To Quarterly Loss

Simply Wall St reports Cal-Maine Foods (CALM) swung in its July 2026 results from net income of $342.48M in the prior year quarter to a net loss of $35.88M, with Q4 sales of $552.58M, about half prior-year. Full-year net income fell to $316.68M on $2.91B sales, and variable dividends were reduced to $0.3550/share in April 2026.

Original reporting
Published Jul 27, 2026, 4:43 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 7:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CALM
Bearish
medium confidence
Mentioned
$CALM
Relevance
6/10
alphai data visualization · based on simplywall.st
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

The profit-to-loss swing and reduced full-year earnings increase uncertainty around near-term cash generation and variable dividend capacity, which can re-rate the stock for income and volatility-sensitive investors.

02

Market read

Investors are likely to reassess earnings volatility, dividend sustainability, and the sensitivity of cash returns to egg pricing and biosecurity shocks.

03

What to watch

The article emphasizes avian influenza risk but does not quantify current flock disruption or pricing recovery, which could reverse the earnings trajectory.

Relevance 6/10Novelty 5/10Timing: after-hours or pre-open read-through to the latest reported quarter results

Background

Cal-Maine’s investment narrative depends on managing a cyclical egg market, protecting flocks from disease, and growing higher-margin specialty and prepared products.

Company-level read

Ticker impact

$CALMBearishMedium confidence
Context

Cal-Maine Foods swung from Q4 net income of $342.48M to a Q4 net loss of $35.88M, with full-year earnings dropping alongside sales contraction.

Expected impact

Likely downside bias for the stock until investors gain clarity on egg pricing, supply stability, and biosecurity impacts.

Evidence & confidence

The article provides specific quarterly and full-year P&L figures plus notes variable dividend reductions tied to net income, which can pressure income-focused demand.

Market effects

Highlights how quickly avian disease and egg-market pricing can flip profitability, reinforcing volatility risk for egg producers.

No specific regional market linkage provided beyond US egg business dynamics.

Limited, as the article frames the catalyst around US flock health and egg economics.

Counterpoint

Full-year results remain profitable, so the Q4 loss may be a temporary trough rather than a structural earnings impairment.

Key entities

  • Cal-Maine Foods

    Reported Q4 sales of $552.58M and swung from net income to net loss, with full-year earnings and EPS declining.

Related articles

$CALMMedAI 8/10

Why Cal-Maine Foods Stock Just Cracked

Cal-Maine Foods (NASDAQ: CALM) shares fell about 3.7% by 9:45 a.m. ET after reporting Q4 results. Analysts expected EPS of $0.11 on $657M sales, but the company reported a loss of $0.76 per share on $552.6M sales. CEO Sherman Miller cited industry oversupply and low wholesale egg prices. 2026 revenue fell 32% and profit fell 73%.

$CALMMedAI 8/10

Cal-Maine Foods Stock Slips on Surprise Q4 Loss

Cal-Maine Foods (NASDAQ:CALM) shares fell after the company reported a fiscal Q4 loss of 76 cents per share, versus analysts expecting a profit of 11 cents. The firm cited historically low inflation-adjusted egg prices. Revenue dropped 49.9% year over year to $552.6 million. Stock was down 2.7% near $84.96.

$CALMMedAI 8/10

Cal-Maine Falls To Loss In Q4, Shares Down

Cal-Maine Foods (CALM) reported a Q4 2026 net loss of $35.88 million versus a $342.48 million profit a year earlier. Net loss per share was $0.76 versus EPS of $7.01. Revenue fell 49.9% to $552.58 million from $1.10 billion. Shares were down about 4.69% premarket to $83.16 on Nasdaq.

$SMCIMed

Stocks making the biggest moves premarket: Super Micro Computer, GE Vernova, Rocket Lab and more

Premarket movers included Super Micro Computer, up about 17% after preliminary Q4 results showed stronger profitability than expected, with revenue near low guidance. GE Vernova fell over 7% despite a revenue beat and raised full-year guidance. Rocket Lab rose about 4% on a $266 million U.S. Air Force contract. Pegasystems dropped over 14% after Q2 missed estimates; others moved on earnings or nuclear/AI news.

$CALMMed

Maine (NASDAQ:CALM) Misses Q2 CY2026 Sales Expectations

Cal-Maine Foods (NASDAQ: CALM) reported Q2 CY2026 revenue of $552.6 million, down 49.9% year over year, missing market expectations. The company posted a GAAP loss of $0.76 per share, better than analysts’ consensus. Management cited strategy to improve product mix and pricing. The stock fell 2.2% to $85.37 after results.